| Quarterly Financials | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 270 | 285 | 278 | 275 | 276 | 691 | 835 | 831 | 1,026 | 1,050 | 1,023 | 964 | 1,098 | 1,163 | 1,186 | 1,255 | 1,326 | 1,409 | 1,381 | 1,468 | 1,578 | 1,748 | 1,902 |
| Expenses | 239 | 253 | 245 | 228 | 514 | 564 | 636 | 634 | 756 | 787 | 729 | 729 | 802 | 818 | 828 | 874 | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,443 |
| EBITDA | 31 | 31 | 32 | 47 | -239 | 127 | 200 | 197 | 270 | 262 | 293 | 235 | 296 | 345 | 359 | 381 | 379 | 433 | 432 | 427 | 422 | 491 | 459 |
| Operating Profit % | 9 % | 10 % | 8 % | 8 % | -101 % | 13 % | 20 % | 21 % | 24 % | 23 % | 25 % | 22 % | 25 % | 28 % | 28 % | 28 % | 26 % | 28 % | 29 % | 27 % | 25 % | 26 % | 23 % |
| Depreciation | 12 | 11 | 11 | 12 | 26 | 52 | 48 | 48 | 54 | 54 | 55 | 58 | 57 | 58 | 57 | 60 | 56 | 58 | 61 | 70 | 77 | 84 | 98 |
| Interest | 10 | 21 | 27 | 25 | 35 | 53 | 46 | 45 | 27 | 27 | 25 | 22 | 22 | 22 | 20 | 20 | 19 | 9 | 11 | 21 | 24 | 34 | 52 |
| Profit Before Tax | 9 | -0 | -6 | 10 | -300 | 22 | 105 | 105 | 190 | 182 | 213 | 154 | 216 | 265 | 281 | 301 | 304 | 366 | 360 | 336 | 321 | 374 | 309 |
| Tax | -0 | 1 | -4 | -43 | 14 | 6 | 15 | 35 | 43 | 37 | 23 | 31 | 44 | -192 | 59 | 50 | 63 | 90 | 70 | 84 | 85 | 92 | 70 |
| Net Profit | 9 | -1 | -2 | 53 | -314 | 17 | 90 | 70 | 147 | 145 | 190 | 124 | 173 | 457 | 222 | 251 | 240 | 277 | 289 | 252 | 236 | 282 | 239 |
| EPS in ₹ | 0.17 | -0.03 | -0.03 | 0.91 | -4.34 | 0.18 | 1.00 | 0.76 | 1.52 | 1.50 | 1.96 | 1.28 | 1.78 | 4.72 | 2.29 | 2.58 | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 |
Max Healthcare Institute
1,089.30
-33.85
(-3.01%)
Market Cap
1,05,895.43 Cr
EPS
10.89
PE Ratio
103.08
Dividend Yield
0.13 %
Industry
Healthcare Services52 Week High
1,227.95
52 Week Low
743.10
PB Ratio
12.43
Debt to Equity
0.13
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from20 analysts
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,089.30 | #1 1,05,895.43 | #10 103.08 | #3 5,584.10 | #4 18.77 | #1 1,058 | #9 -17.46 | 51.00 | |
6,780.95 | 97,499.66 | 74.99 | #1 19,165.50 | 14.74 | 917 | 49.14 | 62.56 | |
649.55 | 49,038.31 | 62.57 | 6,931.20 | 8.99 | 645 | #1 89.49 | 51.60 | |
1,699.95 | 34,740.31 | 44.06 | 5,093.40 | 10.96 | 790 | 2.66 | 63.10 | |
1,269.95 | 34,109.25 | 65.05 | 2,759.20 | #1 25.09 | 326 | 15.71 | 59.10 | |
500.30 | 24,990.64 | 93.82 | 3,723.70 | 22.85 | 205 | -69.22 | 72.68 | |
616.75 | 24,678.57 | 68.22 | 2,511.20 | 12.94 | 336 | 20.76 | 56.67 | |
1,530.85 | 15,546.04 | 63.54 | 1,334.00 | 10.76 | 218 | 10.06 | 74.19 | |
5,500.00 | 12,539.44 | #1 28.46 | 599.90 | 11.69 | 58 | 8.85 | 51.81 | |
1,450.55 | 9,510.68 | 48.56 | 1,095.50 | 21.32 | 177 | 20.14 | 39.35 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
18.77 %
Net Income Growth
-4.16 %
Cash Flow Change
-12.64 %
ROE
-15.51 %
ROCE
4.66 %
EBITDA Margin (Avg.)
1.91 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,824 | 8,544 | 9,189 | 10,102 | 12,000 |
| Fixed Assets | 740 | 1,478 | 2,244 | 2,227 | 2,192 | 2,380 | 6,536 | 7,018 | 7,039 | 8,784 |
| Current Assets | 383 | 289 | 349 | 454 | 447 | 768 | 1,125 | 1,000 | 1,943 | 1,706 |
| Capital Work in Progress | 18 | 12 | 46 | 38 | 87 | 6 | 27 | 151 | 252 | 553 |
| Investments | 143 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
| Other Assets | 552 | 728 | 870 | 1,049 | 1,086 | 1,439 | 1,981 | 2,020 | 2,810 | 2,661 |
| Total Liabilities | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,824 | 8,544 | 9,189 | 10,102 | 12,000 |
| Current Liabilities | 282 | 419 | 381 | 477 | 1,140 | 1,474 | 777 | 757 | 1,046 | 1,249 |
| Non Current Liabilities | 339 | 672 | 1,660 | 1,806 | 1,262 | 1,363 | 2,129 | 2,149 | 1,647 | 2,343 |
| Total Equity | 832 | 1,127 | 1,119 | 1,031 | 963 | 987 | 5,639 | 6,283 | 7,410 | 8,408 |
| Reserve & Surplus | 343 | 587 | 655 | 627 | 426 | 450 | 4,673 | 5,313 | 6,439 | 7,436 |
| Share Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 16 | -40 | 4 | -6 | -2 | 267 | 516 | -318 | 893 | -395 |
| Investing Activities | -194 | -364 | -104 | -124 | -17 | -127 | 206 | -764 | -102 | -1,253 |
| Operating Activities | 64 | 53 | 156 | 166 | 89 | 250 | 118 | 741 | 1,284 | 1,122 |
| Financing Activities | 145 | 271 | -48 | -48 | -74 | 144 | 191 | -294 | -289 | -264 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 70.46 % | 70.46 % | 60.91 % | 60.68 % | 50.64 % | 50.64 % | 23.80 % | 23.78 % | 23.77 % | 23.76 % | 23.76 % | 23.75 % | 23.75 % | 23.74 % | 23.74 % | 23.74 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.01 % | 57.33 % | 56.98 % | 57.29 % | 56.93 % |
| DIIs | 4.86 % | 7.93 % | 8.70 % | 15.60 % | 17.49 % | 19.26 % | 21.00 % | 20.47 % | 19.35 % | 11.90 % | 11.32 % | 11.34 % | 14.96 % | 15.36 % | 15.14 % | 15.55 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.18 % | 5.76 % | 5.20 % | 5.23 % | 5.41 % | 4.94 % | 4.54 % | 4.36 % | 3.72 % | 3.54 % | 3.55 % | 3.34 % | 3.29 % | 3.24 % | 3.18 % | 3.13 % |
| Others | 19.50 % | 15.84 % | 25.18 % | 18.49 % | 26.46 % | 25.16 % | 50.65 % | 51.38 % | 53.15 % | 60.80 % | 61.36 % | 61.56 % | 0.67 % | 0.67 % | 0.65 % | 0.64 % |
| No of Share Holders | 45,339 | 70,655 | 91,937 | 1,11,877 | 1,20,079 | 1,05,000 | 1,01,659 | 1,11,701 | 1,04,656 | 1,11,374 | 1,18,635 | 1,11,338 | 1,27,009 | 1,36,254 | 1,37,856 | 1,40,028 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.14 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Credit RatingApr 01, 2025
Apr 01, 2025Announcement under Regulation 30 (LODR)-Credit RatingApr 01, 2025
Apr 01, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 22, 2025
Mar 22, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 14, 2025
Mar 14, 2025Outcome Of Board MeetingMar 12, 2025
Mar 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Feb 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Feb 27, 2025Approval Of Scheme Of Amalgamation Between ALPS Hospital Limited And Max Hospitals And Allied Services LimitedFeb 26, 2025
Feb 26, 2025Approval Of Scheme Of Amalgamation Between ALPS Hospital Limited And Max Hospitals And Allied Services LimitedFeb 26, 2025
Feb 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Feb 11, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 31, 2025
Jan 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Jan 31, 2025Audio Recording Of Earnings Call Held On January 31 2025Jan 31, 2025
Jan 31, 2025Integrated Filing (Financial)Jan 30, 2025
Jan 30, 2025Agreement To Lease For Setting Up ~500 Bedded Build-To-Suit Hospital At Thane MaharashtraJan 30, 2025
Jan 30, 2025Presentation On Earnings UpdateJan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-AcquisitionJan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2025
Jan 30, 2025Board Meeting Outcome for Meeting Held On January 30 2025Jan 30, 2025
Jan 30, 2025Results- Financial Results For Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 29, 2025
Jan 29, 2025Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Jan 29, 2025
Jan 29, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 27, 2025
Jan 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 24, 2025
Jan 24, 2025Board Meeting Intimation for Consideration And Approval Of Financial ResultsJan 24, 2025
Jan 24, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 23, 2025
Jan 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Change Of Name Of Registrar And Share Transfer AgentJan 01, 2025
Jan 01, 2025Closure of Trading WindowDec 27, 2024
Dec 27, 2024Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Dec 03, 2024
Dec 03, 2024Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2024
Nov 13, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2024
Nov 12, 2024Announcement under Regulation 30 (LODR)-Updates on AcquisitionNov 12, 2024
Nov 12, 2024Announcement under Regulation 30 (LODR)-Investor PresentationNov 11, 2024
Nov 11, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2024
Nov 07, 2024Audio Recording Of Earnings Call Held On November 7, 2024Nov 07, 2024
Nov 07, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2024
Nov 07, 2024Presentation On Earnings UpdateNov 05, 2024
Nov 05, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2024
Nov 05, 2024Board Meeting Outcome for Meeting Held On November 5, 2024Nov 05, 2024
Nov 05, 2024Results - Financial Results For Quarter And Half Year Ended September 30, 2024Nov 05, 2024
Nov 05, 2024Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Nov 05, 2024
Nov 05, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 30, 2024
Oct 30, 2024Technical Indicators
RSI(14)
Neutral 51.00
ATR(14)
Less Volatile 44.30
STOCH(9,6)
Neutral 32.59
STOCH RSI(14)
Oversold 13.70
MACD(12,26)
Bearish -2.80
ADX(14)
Weak Trend 25.00
UO(9)
Bearish 44.80
ROC(12)
Downtrend And Accelerating -4.97
WillR(14)
Oversold -80.51
About Max Healthcare Institute
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Max Healthcare has two strategic business units: Max Lab, which provides diagnostic services outside its hospital network, and Max@Home, offering health and wellness services at home. The company is listed on the BSE and NSE, with Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. as its current promoters.
Website
Chairperson NameAbhay Soi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
